1. Home
  2. AXIL vs INCR Comparison

AXIL vs INCR Comparison

Compare AXIL & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AXIL Brands Inc.

AXIL

AXIL Brands Inc.

N/A

Current Price

$6.47

Market Cap

45.4M

ML Signal

N/A

Logo Intercure Ltd.

INCR

Intercure Ltd.

HOLD

Current Price

$0.91

Market Cap

50.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXIL
INCR
Founded
2015
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.4M
50.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AXIL
INCR
Price
$6.47
$0.91
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
17.9K
43.0K
Earning Date
01-08-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.17
N/A
Revenue
$27,664,753.00
$72,158,312.00
Revenue This Year
N/A
$69.54
Revenue Next Year
N/A
$41.75
P/E Ratio
$39.24
N/A
Revenue Growth
4.18
N/A
52 Week Low
$4.04
$0.68
52 Week High
$10.75
$1.77

Technical Indicators

Market Signals
Indicator
AXIL
INCR
Relative Strength Index (RSI) 38.82 44.79
Support Level $6.40 $0.86
Resistance Level $6.83 $0.96
Average True Range (ATR) 0.50 0.05
MACD -0.14 0.01
Stochastic Oscillator 7.17 63.00

Price Performance

Historical Comparison
AXIL
INCR

About AXIL AXIL Brands Inc.

AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Share on Social Networks: